Impaired Digital Reactive Hyperemia and the Risk of Restenosis After Primary Coronary Intervention in Patients With Acute Coronary Syndrome

Journal of Atherosclerosis and Thrombosis - Japan
doi 10.5551/jat.19497
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Atherosclerosis Society

Related search

Erythropoietin in Patients With Acute Coronary Syndrome and Its Cardioprotective Action After Percutaneous Coronary Intervention

Circulation Journal
MedicineCardiovascular MedicineCardiology
2009English

Predictors of Mortality in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Heart
2003English

Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention

Frontiers in Physiology
Physiology
2019English

High Serum Concentration of Sulfatide Is a Risk Factor for Restenosis in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

Journal of Postgenomics Drug & Biomarker Development
2015English

Percutaneous Coronary Intervention in Patients With Anomalous Origin of Coronary Artery Presenting With Acute Coronary Syndrome: A Case Series

Journal of Cardiovascular Disease Research
Cardiovascular MedicineCardiology
2013English

Protection Against Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Angiology
Cardiovascular MedicineCardiology
2018English

The Prognostic Value of IL-8 for Cardiac Events and Restenosis in Patients With Coronary Heart Diseases After Percutaneous Coronary Intervention

Japanese Heart Journal
2003English

Severely Impaired Microvascular Reactivity in Diabetic Patients With an Acute Coronary Syndrome

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2016English

Mechanism of Reactive Hyperemia in Coronary and Femoral Circulation

Folia Pharmacologica Japonica
Pharmacology
1967English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy